Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neurological Sciences

• Publication date

  2008-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jns.2008.06.025PMID 18656208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of complement factor H Y402H gene polymorphism with Alzheimer's disease

  2008cited by this paper
• Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype

  2007cited by this paper
• Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene

  2006cited by this paper
• ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

  2006cited by this paper
• Genetic influences on outcome following acute neurological insults

  2005cited by this paper
• EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives

  2005cited by this paper
• Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis

  2004cited by this paper
• APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

  2004cited by this paper
• APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury.

  2004cited by this paper
• Head injury and dementia

  2004cited by this paper
• APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42

  2004cited by this paper
• APOE-ε4 predicts dementia but not other psychiatric disorders after traumatic brain injury

  2004cited by this paper
• Age at onset of Parkinson disease and apolipoprotein E genotypes.

  2002cited by this paper
• Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis

  2001cited by this paper
• Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.

  2001cited by this paper
• No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

  2000cited by this paper
• Apolipoprotein E and neuromuscular disease: a critical review of the literature.

  2000cited by this paper
• Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis

  1998cited by this paper
• Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing.

  1997cited by this paper
• Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis.

  1996cited by this paper
• Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease.

  1995cited by this paper
• Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis.

  1995cited by this paper
• Apolipoprotein E ϵ4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis

  1995cited by this paper
• Allele ε4 of apolipoprotein E shows a dose effect on age at onset of Pick disease

  1995cited by this paper
• Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase

  1995cited by this paper
• APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.

  1994cited by this paper
• Linkage analysis in familial Alzheimer disease: Description of the Duke and Boston data sets

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Apolipoprotein E polymorphism and Alzheimer's disease.

  1993cited by this paper
• Practical statistics for medical research

  1990cited by this paper

• APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases

  2025cites this paper
• Sex-Specific Markers of Neuroinflammation and Neurodegeneration in the Spinal Cord Proteome of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

  2025cites this paper
• Machine learning identified novel players in lipid metabolism, endosomal trafficking, and iron metabolism of the ALS spinal cord

  2025cites this paper
• Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

  2023influential citation
• Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis

  2022cites this paper
• Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon?

  2021cites this paper
• Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review

  2021cites this paper
• Association of apolipoprotein E ε4 allele and amyotrophic lateral sclerosis in Chinese population

  2021cites this paper
• Lipid Biomarkers for Amyotrophic Lateral Sclerosis

  2019cites this paper
• A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system

  2019cites this paper
• Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis

  2018cites this paper
• Apolipoprotein E genotypes and longevity across dementia disorders

  2018cites this paper
• Is Apolipoprotein E ε2 Associated with Delayed Onset of Non-Lesional Temporal Lobe Epilepsy?

  2017cites this paper
• Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta‐analysis

  2017cites this paper
• The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.

  2016cites this paper
• The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs

  2015cites this paper
• Familial Amyotrophic Lateral Sclerosis.

  2015cites this paper
• The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs

  2015cites this paper
• Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.

  2015cites this paper
• Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

  2015influential citation
• The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs

  2015cites this paper
• MOLECULAR AND GENETIC CHARACTERIZATION OF ALS PATIENTS

  2014cites this paper
• Lack of association between APOE gene polymorphisms and amyotrophic lateral sclerosis: A comprehensive meta-analysis

  2014cites this paper
• Targeted Exon Capture and Sequencing in Sporadic Amyotrophic Lateral Sclerosis

  2014influential citation
• The genetics and spread of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

  2013cites this paper
• Genetic and epigenetic studies of amyotrophic lateral sclerosis

  2013cites this paper
• Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.

  2013cites this paper
• Study of Cyclophilin A Function in Models of Amyotrophic Lateral Sclerosis

  2013cites this paper
• Homozygous SMN2 deletion is a protective factor in the Swedish ALS population

  2012cites this paper
• Apolipoprotein E Genotype: The Innocent Bystander or Active Bridge Between Metabolic Syndrome and Cognitive Impairment?

  2012cites this paper
• The genetics and neuropathology of amyotrophic lateral sclerosis

  2012cites this paper
• APOE ε4 allele is associated with an increased risk of bulbar‐onset amyotrophic lateral sclerosis in men

  2011cites this paper
• Does apolipoprotein E genotype modify the clinical expression of ALS?

  2011cites this paper
• Phenotypic Heterogeneity in a SOD1 G93D Italian ALS Family: An Example of Human Model to Study a Complex Disease

  2011cites this paper
• Apolipoprotein E in Alzheimer's disease and other neurological disorders.

  2011cites this paper
• Genetic Risk Factors: Their Function and Comorbidities in Alzheimer's Disease

  2011cites this paper
• Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease

  2011cites this paper
• Altered oxidative stress profile in the cortex of mice fed an enriched branched‐chain amino acids diet: Possible link with amyotrophic lateral sclerosis?

  2011cites this paper
• Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

  2011cites this paper
• Mutant ApoA-1 Amyloidosis in a Family of Five Siblings With Motor Neuron Disease and Dementia

  2011cites this paper
• 2 International Journal of Alzheimer ’ s Disease 2 . Structural Organization and Toxicological Properties of the APOE Protein 2

  2011cites this paper
• A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS

  2010cites this paper
• Mutant Superoxide Dismutase-1-caused pathogenesis in Amyotrophic Lateral Sclerosis

  2010cites this paper
• APOE ε4 and Cognitive Dysfunction in Multiple Sclerosis: A Review

  2010cites this paper
• APOE epsilon4 and cognitive dysfunction in multiple sclerosis: a review.

  2010cites this paper